Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

21 Jul 2006 15:17

Volex Group PLC21 July 2006 Volex Group PLC ("Volex" or the "Company") The Company was informed on 21 July 2006 that, pursuant to the purchase of200,000 ordinary shares of 25p each in the Company ("Ordinary Shares"), CycladicCapital LLP ("Cycladic") is now interested in 12,587,610 Ordinary Shares,representing approximately 22.7 per cent. of the Company's issued share capital.Of these Ordinary Shares 100,000 were purchased at a price of 105.5p per shareon 17 July 2006 and a further 100,000 were purchased at a price of 100p pershare on 19 July 2006. Through his position as Partner in Cycladic, DimitriGoulandris, a director of the Company holds an interest in these 12,587,610Ordinary Shares. 21 July 2006 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.